Other Amazon launches AI drug discovery platform Pharmaceutical TechnologyAmazon has already collaborated with Memorial Sloan Kettering Cancer Center with its AI drug discovery software.OtherRead full story pharminent April 15, 2026 Pharmaceutical Technology Amazon has already collaborated with Memorial Sloan Kettering Cancer Center with its AI drug discovery software. OtherRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: J&J leans on Tremfya, cancer drugs to overcome Stelara lossesNext: S16 Ep52: Medical Crossfire: PD-L1 Inhibition in Advanced Cutaneous Squamous Cell Carcinoma — Mechanistic Rationale and Clinical Application Related Stories Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026 Other All eyes on Revolution, bispecific antibodies and more at ASCO26 pharminent May 26, 2026
